DXCM vs LTRN · P/E 63, rev $2.50B vs $35.1M cap
DexCom Inc (DXCM) versus Lantern Pharma Inc (LTRN) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Lantern Pharma Inc (LTRN) is a biotechnology company listed on US.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
LTRN does not have a complete income-statement cache yet.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. LTRN currently screens at market cap $35.1M.
Not investment advice. Open the DXCM and LTRN stock pages for the full models.
Not investment advice.